The Health Resources and Services Administration recently surprised the 340B Drug Pricing Program community with the release of its regulations pertaining to drug manufacturer ceiling price calculations and civil monetary penalties.
Please see full publication below for more information.
LOADING PDF: If there are any problems, click here to download the file.